By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Personalized medicine software company MediSapiens has raised $1 million in seed funding from Veraventure, ETF III, VTT Ventures, and Lifeline Ventures.

The Helsinki-based company provides a software database platform that provides genomic data about cancer and cancer treatments that can be used to develop personalized therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.